Immunotherapy for Infectious Diseases

318 Casadevall
16. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic
malignancy: ten years’ experience at a cancer center and implications for management.
Blood 1998; 90:999–1008.
17. Verschraegen CF, Van Besiern KW, Dignani C, Hester JP, Anderson BS, Anaissie EJ. Invasive
aspergillus sinusitis during bone marrow transplantation. Scand J Infect Dis 1997;
29:436–438.
18. Di Mario A, Sica S, Salutari P, Ortu-La Barbera E, Marra R, Leone G. Granulocyte
colony-stimulating factor-primed leukocyte transfusions in Candida tropicalis fungemia
in neutropenic patients. Haematologica 1997; 82:362–363.
19. Catalano M, Fontana R, Scarpato N, Picardi M, Rocco S, Rotoli B. Combined treatment
with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an
aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
Haematologica 1997; 82:71–72.
20. Mabry RL, Mabry CS. Immunotherapy for allergic fungal sinusitis: the second year. Otolaryngol
Head Neck Surg 1997; 117:367–371.
21. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated
with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med
1981; 304:1185–1189.
22. Boxer LA, Ingraham LM, Allen J, Oseas RS, Baehner RL. Amphotericin-B promotes
leukocyte aggregation of nylon-wool-fiber-treated polymophonuclear leukocytes. Blood
1981; 58:518–523.
23. Dana BW, Durie BGM, White RF, Huestis DW. Concomitant administration of granulocyte
transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary
toxicity. Blood 1998; 57:90–93.
24. Burch WM, Snyderman R. Induction of cellular immunity to Coccidioides immitis after
sensitization with dinitrochlorobenzene. Ann Intern Med 1992; 96:329–331.
25. Newman SL, Gootee L, Brunner G, Deepe GS Jr. Chloroquine induces human
macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular
iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 1994;
93:1422–1429.
26. Levitz SM, Harrison TS, Tabuni A, Liu X. Chloroquine induces human mononuclear
phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of
iron deprivation. J Clin Invest 1997; 100:1640–1646.
27. Mazzola R, Barluzzi R, Brozzetti A, et al. Enhanced resistance to Cryptococcus neoformans
infection induced by chloroquine in a murine model of meningoencephalitis. Antimicrob
Agents Chemother. 1997; 41:802–807.
28. Kitchen LW. Adjunctive immunologic therapy for Cryptococcus neoformans infections.
Clin Infect Dis 1996; 23:209–210.
29. Kitchen LW, Ross JA, Turner BS, Hernandez JE, Mather FJ. Diethylcarbamazine enhances
blood microbicidal activity. Adv Ther 1995; 12:22–29.
30. Kitchen LW, Ross JA, Hernandez JE, Zarraga AL, Mather FJ. Effect of administration of
diethylcarbamazine on experimental bacterial and fungal infections in mice. Int J Antimicrob
Agents 1992; 1:259–268.
31. Nemunitis J. A comparative review of colonly-stimulating factors. Drugs 1997;
54:709–729.
32. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocytemacrophage
colony-stimulating factor. N Engl J Med 1992; 327:28–35.
33. Enelow RI, Sullivan GW, Carper HT, Mandell GL. Cytokine-induced human multinucleated
giant cells have enhanced candidacidal activity and oxidative capacity compared with
macrophages. J Infect Dis 1992; 166:664–668.
34. Offner F. Hematopoietic growth factors in cancer patients with invasive fungal infections.
Eur J Clin Microbiol Infect Dis 1997; 16:50–63.